Ligand validation:1WQW

BT5: BIOTINYL-5-AMP

BT5 is a Ligand Of Interest in 1WQW designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1WQW_BT5_A_1301	64%	27%	0.125	0.925	1.5	1.59	5	5	1	0	100%	1
1WQW_BT5_B_1302	59%	25%	0.13	0.914	1.55	1.66	5	6	6	0	100%	1
2DVE_BT5_B_1301	90%	14%	0.077	0.959	2.2	1.87	10	12	0	0	100%	1
2DEQ_BT5_B_1301	89%	8%	0.082	0.961	2.42	2.36	6	11	0	0	100%	1
2DJZ_BT5_A_1301	87%	14%	0.086	0.957	2.29	1.81	11	10	0	0	100%	1
2DXU_BT5_B_2301	85%	14%	0.09	0.955	2.19	1.85	11	12	0	0	100%	1
2DKG_BT5_B_1302	84%	11%	0.091	0.954	2.33	2	9	12	1	0	100%	1
4OP0_BT5_A_301	89%	15%	0.085	0.963	2.05	1.93	6	9	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.